Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
USA Lab is available to MIT Sloan students and graduate students from across the broader MIT campus.
By
Since its inception, the program has helped launch 70 thriving companies
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
Wharton’s Ethan Mollick and MIT Sloan’s Bill Aulet discuss the ways generative artificial intelligence is remaking the competitive landscape of entrepreneurship.
The Climate Policy Center will connect current and future climate research to policy, measuring the impact and implications of a variety of technologies on the climate system as a whole.
Twelve teams of students and postdocs across the MIT community presented innovative startup ideas with potential for real-world impact.